StockData
PetMed Express Inc logo

PetMed Express Inc (PETS) stock

PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3063% below fair value
$0.94−0.05 (-4.96%)

Close on Nov 13, 2026Market cap $20.38MP/E –Yield 0.00%

PetMed Express total assets

Total assets on the balance sheet at the end of each period.

PetMed Express's total assets was $59.40M at Sep 30, 2026. For fiscal 2026 it was $81.19M, down 45.4% from the year before. Over ten years it grew -1.1% a year on average. The highest annual figure on record is $187.50M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2026Mar 31, 2026$81.19M-45.4%
FY2025Mar 31, 2025$148.70M-12.5%
FY2024Mar 31, 2024$169.88M+1.4%
FY2023Mar 31, 2023$167.48M-6.8%
FY2022Mar 31, 2022$179.70M-4.2%
FY2021Mar 31, 2021$187.50M+20.7%
FY2020Mar 31, 2020$155.32M+0.6%
FY2019Mar 31, 2019$154.43M+14.5%
FY2018Mar 31, 2018$134.84M+19.5%
FY2017Mar 31, 2017$112.81M+25.0%
FY2016Mar 31, 2016$90.28M+9.0%
FY2015Mar 31, 2015$82.85M+5.7%
FY2014Mar 31, 2014$78.38M+7.1%
FY2013Mar 31, 2013$73.18M-19.6%
FY2012Mar 31, 2012$91.06M-14.3%
FY2011Mar 31, 2011$106.29M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ3 2026Sep 30, 2026$59.40M-40.8%
Q1 FY2027CQ2 2026Jun 30, 2026$63.76M-41.9%
Q4 FY2026CQ1 2026Mar 31, 2026$81.19M-45.4%
Q3 FY2026CQ4 2025Dec 31, 2025$87.97M-39.2%
Q2 FY2026CQ3 2025Sep 30, 2025$100.30M-31.3%
Q1 FY2026CQ2 2025Jun 30, 2025$109.84M-28.1%
Q4 FY2025CQ1 2025Mar 31, 2025$148.70M-12.5%
Q3 FY2025CQ4 2024Dec 31, 2024$144.80M-16.5%
Q2 FY2025CQ3 2024Sep 30, 2024$146.03M-10.2%
Q1 FY2025CQ2 2024Jun 30, 2024$152.71M-17.1%
Q4 FY2024CQ1 2024Mar 31, 2024$169.88M+1.4%
Q3 FY2024CQ4 2023Dec 31, 2023$173.35M+2.2%
Q2 FY2024CQ3 2023Sep 30, 2023$162.70M-3.9%
Q1 FY2024CQ2 2023Jun 30, 2023$184.28M+11.9%
Q4 FY2023CQ1 2023Mar 31, 2023$167.48M-6.8%
Q3 FY2023CQ4 2022Dec 31, 2022$169.61M+0.7%
Q2 FY2023CQ3 2022Sep 30, 2022$169.27M+6.2%
Q1 FY2023CQ2 2022Jun 30, 2022$164.74M-5.0%
Q4 FY2022CQ1 2022Mar 31, 2022$179.70M-4.2%
Q3 FY2022CQ4 2021Dec 31, 2021$168.43M+0.6%
Q2 FY2022CQ3 2021Sep 30, 2021$159.39M+0.3%
Q1 FY2022CQ2 2021Jun 30, 2021$173.32M+6.5%
Q4 FY2021CQ1 2021Mar 31, 2021$187.50M+20.7%
Q3 FY2021CQ4 2020Dec 31, 2020$167.37M+11.9%
Q2 FY2021CQ3 2020Sep 30, 2020$158.95M+9.2%
Q1 FY2021CQ2 2020Jun 30, 2020$162.76M+12.4%
Q4 FY2020CQ1 2020Mar 31, 2020$155.32M+0.6%
Q3 FY2020CQ4 2019Dec 31, 2019$149.54M-4.7%
Q2 FY2020CQ3 2019Sep 30, 2019$145.54M-1.7%
Q1 FY2020CQ2 2019Jun 30, 2019$144.84M-5.1%
Q4 FY2019CQ1 2019Mar 31, 2019$154.43M+14.5%
Q3 FY2019CQ4 2018Dec 31, 2018$156.92M+15.7%
Q2 FY2019CQ3 2018Sep 30, 2018$148.07M+18.6%
Q1 FY2019CQ2 2018Jun 30, 2018$152.67M+21.5%
Q4 FY2018CQ1 2018Mar 31, 2018$134.84M+19.5%
Q3 FY2018CQ4 2017Dec 31, 2017$135.59M+38.9%
Q2 FY2018CQ3 2017Sep 30, 2017$124.88M–
Q1 FY2018CQ2 2017Jun 30, 2017$125.67M–
Q4 FY2017CQ1 2017Mar 31, 2017$112.81M–
Q3 FY2017CQ4 2016Dec 31, 2016$97.62M–

More PetMed Express figures

See a number that looks wrong?